Vivos Therapeutics (VVOS) Treasury Shares (2019)
Vivos Therapeutics (VVOS) posted quarterly Treasury Shares of $730000.0 for Q4 2019.
Vivos Therapeutics (VVOS) Treasury Shares (2019) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Treasury Shares for 1 consecutive years, with $730000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Treasury Shares changed N/A year-over-year to $730000.0; the TTM figure through Dec 2019 stood at $730000.0 (changed N/A YoY), while the FY2019 annual figure was $730000.0, changed N/A from the prior year.
- Treasury Shares held at $730000.0 in Q4 2019 per VVOS's latest filing.
- Across five years, Treasury Shares topped out at $730000.0 in Q4 2019 and bottomed at $730000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 267.91 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 303.21 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 85.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.73 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 525.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 16.27 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 730,000.00 |
| Dec 31, 2019 | 730,000.00 |